Literature DB >> 28611129

Microvascular Paradigm in Heart Failure With Preserved Ejection Fraction: A Quest for Proof of Concept.

Mark T Waddingham1, Walter J Paulus2.   

Abstract

Entities:  

Keywords:  Editorials; diastolic dysfunction; fibrosis; heart failure; microvascular dysfunction; myocardium

Mesh：

Year:  2017        PMID： 28611129     DOI： 10.1161/CIRCHEARTFAILURE.117.004179

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  4 in total

Review 1.  Myocardial ischemia and coronary disease in heart failure.

Authors:  Beniamino R Pagliaro; Francesco Cannata; Giulio G Stefanini; Leonardo Bolognese
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 2.  Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?

Authors:  Islam Y Elgendy; Carl J Pepine
Journal:  Am J Med       Date:  2019-01-23       Impact factor: 4.965

Review 3.  Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.

Authors:  Ambarish Pandey; Sanjiv J Shah; Javed Butler; Dean L Kellogg; Gregory D Lewis; Daniel E Forman; Robert J Mentz; Barry A Borlaug; Marc A Simon; Julio A Chirinos; Roger A Fielding; Elena Volpi; Anthony J A Molina; Mark J Haykowsky; Flora Sam; Bret H Goodpaster; Alain G Bertoni; Jamie N Justice; James P White; Jingzhone Ding; Scott L Hummel; Nathan K LeBrasseur; George E Taffet; Iraklis I Pipinos; Dalane Kitzman
Journal:  J Am Coll Cardiol       Date:  2021-09-14       Impact factor: 27.203

4.  Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment.

Authors:  Bogdan Batko; Pawel Maga; Karol Urbanski; Natalia Ryszawa-Mrozek; Agata Schramm-Luc; Mateusz Koziej; Tomasz Mikolajczyk; Eilidh McGinnigle; Marta Czesnikiewicz-Guzik; Piotr Ceranowicz; Tomasz J Guzik
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.